Current concepts in managing central serous chorioretinopathy.

@article{Fine2014CurrentCI,
  title={Current concepts in managing central serous chorioretinopathy.},
  author={Howard F. Fine and Michael D. Ober and Seenu M. Hariprasad},
  journal={Ophthalmic surgery, lasers & imaging retina},
  year={2014},
  volume={45 1},
  pages={
          9-13
        }
}
Central serous chorioretinopathy (CSC) affects roughly 10 men and two women per 100,000 people, and they are often younger, working-aged individuals with high visual demands. Randomized clinical trials in CSC are scarce and typically evaluate dozens of patients1-12 (Table, page 11) rather than the hundreds or even thousands of patients evaluated in trials for age-related macular degeneration (AMD), retinal vein occlusion, and diabetic retinopathy. Unfortunately, to date there are no FDAapproved… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 30 REFERENCES

Similar Papers

Loading similar papers…